Feature
Anticoagulants
Dabigatran: how the drug company withheld important analyses
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4670 (Published 23 July 2014) Cite this as: BMJ 2014;349:g4670Concerns over data in key dabigatran trial
Dabigatran, bleeding, and the regulators
The trouble with dabigatran
Article usage
Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.